Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 38
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Dairy Sci ; 105(5): 4272-4288, 2022 May.
Artigo em Inglês | MEDLINE | ID: mdl-35221068

RESUMO

This research explores possible options to reduce greenhouse gas (GHG) emissions in the Australian dairy industry by (1) including an environmental component in the national breeding program and (2) estimating the economic and environmental impacts of implementation of the subsequent indexes. A total of 12 possible selection indexes were considered. These indexes were developed to predict changes in gross per-animal methane production (using 3 scenarios depending on availability and efficacy of a direct methane trait breeding value prediction) with 4 different carbon prices, integrating them into an augmentation of the current conventional national selection index. Although some economic response is lost with inclusion of the GHG subindexes in the Balanced Performance Index, options do exist where this loss is marginal and, even in scenarios where all selection pressure is based on the environmental weighting, economic progress is still made in all cases. When including environmental traits within an index, if a relatively low percentage of economic gain or index progression is sacrificed, then approximately 40 to 50% of the maximum possible reductions in emissions may be achieved. This concurrent selection of estimated breeding values that have a correlated favorable response in emissions in addition to direct selection on a residual methane trait allows a high level of methane reduction to be achieved with a realized cost to farmers that is far lower than the economic value placed on carbon. By implementing a GHG subindex in the national breeding program, we can achieve up to a 7.9% decrease in residual methane and 9 times the reduction in gross emissions in 10 yr, compared with the current breeding program, with little to no cost to farmers. By 2050, selection based on one of the more moderate index scenarios at a carbon price of AUD$250/t (AUD$1 = US$0.71), or opportunity cost to farmers of AUD$87.22, will reduce gross emissions by 8.23% and emissions intensity by 21.25%, therefore offering a mitigation strategy that will be effective at reducing emissions with little compromise to profit.


Assuntos
Indústria de Laticínios , Gases de Efeito Estufa , Animais , Austrália , Carbono , Metano , Leite , Seleção Genética
2.
J Dairy Sci ; 104(10): 10979-10990, 2021 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-34334195

RESUMO

The dairy industry has been scrutinized for the environmental impact associated with rearing and maintaining cattle for dairy production. There are 3 possible opportunities to reduce emissions through genetic selection: (1) a direct methane trait, (2) a reduction in replacements, and (3) an increase in productivity. Our aim was to estimate the independent effects of traits in the Australian National Breeding Objective on the gross methane production and methane intensity (EI) of the Australian dairy herd of average genetic potential. Based on similar published research, the traits determined to have an effect on emissions include production, fertility, survival, health, and feed efficiency. The independent effect of each trait on the gross emissions produced per animal due to genetic improvement and change in EI due to genetic improvement (intensity value, IV) were estimated and compared. Based on an average Australian dairy herd, the gross emissions emitted per cow per year were 4,297.86 kg of carbon dioxide equivalents (CO2-eq). The annual product output, expressed in protein equivalents (protein-eq), and EI per cow were 339.39 kg of protein-eq and 12.67 kg of CO2-eq/kg of protein-eq, respectively. Of the traits included in the National Breeding Objective, genetic progress in survival and feed saved were consistently shown to result in a favorable environmental impact. Conversely, production traits had an unfavorable environmental impact when considering gross emissions, and favorable when considering EI. Fertility had minimal impact as its effects were primarily accounted for through survival. Mastitis resistance only affected IV coefficients and to a very limited extent. These coefficients may be used in selection indexes to apply emphasis on traits based on their environmental impact, as well as applied by governments and stakeholders to track trends in industry emissions. Although initiatives are underway to develop breeding values to reduce methane by combining small methane data sets internationally, alternative options to reduce emissions by utilizing selection indexes should be further explored.


Assuntos
Metano , Leite , Animais , Austrália , Bovinos/genética , Indústria de Laticínios , Meio Ambiente , Feminino
3.
J Dairy Sci ; 104(8): 8983-9001, 2021 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-34001361

RESUMO

Selecting for lower methane (CH4) emitting animals is one of the best approaches to reduce CH4 given that genetic progress is permanent and cumulative over generations. As genetic selection requires a large number of animals with records and few countries actively record CH4, combining data from different countries could help to expedite accurate genetic parameters for CH4 traits and build a future genomic reference population. Additionally, if we want to include CH4 in the breeding goal, it is important to know the genetic correlations of CH4 traits with other economically important traits. Therefore, the aim of this study was first to estimate genetic parameters of 7 suggested methane traits, as well as genetic correlations between methane traits and production, maintenance, and efficiency traits using a multicountry database. The second aim was to estimate genetic correlations within parities and stages of lactation for CH4. The third aim was to evaluate the expected response of economically important traits by including CH4 traits in the breeding goal. A total of 15,320 methane production (MeP, g/d) records from 2,990 cows belonging to 4 countries (Canada, Australia, Switzerland, and Denmark) were analyzed. Records on dry matter intake (DMI), body weight (BW), body condition score, and milk yield (MY) were also available. Additional traits such as methane yield (MeY; g/kg DMI), methane intensity (MeI; g/kg energy-corrected milk), a genetic standardized methane production, and 3 definitions of residual methane production (g/d), residual feed intake, metabolic BW (MBW), BW change, and energy-corrected milk were calculated. The estimated heritability of MeP was 0.21, whereas heritability estimates for MeY and MeI were 0.30 and 0.38, and for the residual methane traits heritability ranged from 0.13 to 0.16. Genetic correlations between different methane traits were moderate to high (0.41 to 0.97). Genetic correlations between MeP and economically important traits ranged from 0.29 (MY) to 0.65 (BW and MBW), being 0.41 for DMI. Selection index calculations showed that residual methane had the most potential for inclusion in the breeding goal when compared with MeP, MeY, and MeI, as residual methane allows for selection of low methane emitting animals without compromising other economically important traits. Inclusion of residual feed intake in the breeding goal could further reduce methane, as the correlation with residual methane is moderate and elicits a favorable correlated response. Adding a negative economic value for methane could facilitate a substantial reduction in methane emissions while maintaining an increase in milk production.


Assuntos
Lactação , Metano , Animais , Austrália , Canadá , Bovinos/genética , Dieta , Feminino , Lactação/genética , Leite , Suíça
4.
Animal ; 15(1): 100005, 2021 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-33573960

RESUMO

A recently developed methodological approach for determining the greenhouse gas emissions impact of national breeding programs was applied to measure the effects of current and future breeding goals on the emission intensity (EI) of the Canadian dairy industry. Emission intensity is the ratio of greenhouse gas outputted in comparison to the product generated. Traits under investigation affected EI by either decreasing the direct emissions yield (i.e. increasing feed performance), changing herd structure (i.e. prolonging herd life) or through the dilution effect of increased production (i.e. increasing fat yield). The intensity value (IV) of each trait, defined as the change in emissions' intensity per unit change in each trait, was calculated for each of the investigated traits. The IV trend of these traits was compared for the current and prospective selection index, as well as for a system with and without quota (the supply management policy designed to prevent overproduction). The overall EI of the average genetic merit Canadian dairy herd per breeding female was 5.07 kg CO2eq/kg protein equivalent output. The annual reduction in EI due to the improvement of production traits was -0.027, -0.018 and -0.006 for fat, protein and milk other solids, respectively. The functional traits, herd life and mastitis resistance, had more modest effects (-0.008 and -0.001, respectively). These results are consistent with international studies that identified traits related to production, survival, health and fertility as having the largest impact on the environmental footprint of dairy cattle. Overall, the dairy industry is becoming more efficient by reducing its EI through selection of environmentally favorable traits, with a 1% annual reduction of EI in Canada.


Assuntos
Indústria de Laticínios , Leite , Animais , Canadá , Bovinos/genética , Meio Ambiente , Feminino , Estudos Prospectivos
5.
J Dairy Sci ; 104(1): 539-549, 2021 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-33131823

RESUMO

Methane is a greenhouse gas of high interest to the dairy industry, with 57% of Australia's dairy emissions attributed to enteric methane. Enteric methane emissions also constitute a loss of approximately 6.5% of ingested energy. Genetic selection offers a unique mitigation strategy to decrease the methane emissions of dairy cattle, while simultaneously improving their energy efficiency. Breeding objectives should focus on improving the overall sustainability of dairy cattle by reducing methane emissions without negatively affecting important economic traits. Common definitions for methane production, methane yield, and methane intensity are widely accepted, but there is not yet consensus for the most appropriate method to calculate residual methane production, as the different methods have not been compared. In this study, we examined 9 definitions of residual methane production. Records of individual cow methane, dry matter intake (DMI), and energy corrected milk (ECM) were obtained from 379 animals and measured over a 5-d period from 12 batches across 5 yr using the SF6 tracer method and an electronic feed recording system, respectively. The 9 methods of calculating residual methane involved genetic and phenotypic regression of methane production on a combination of DMI and ECM corrected for days in milk, parity, and experimental batch using phenotypes or direct genomic values. As direct genomic values (DGV) for DMI are not routinely evaluated in Australia at this time, DGV for FeedSaved, which is derived from DGV for residual feed intake and estimated breeding value for bodyweight, were used. Heritability estimates were calculated using univariate models, and correlations were estimated using bivariate models corrected for the fixed effects of year-batch, days in milk, and lactation number, and fitted using a genomic relationship matrix. Residual methane production candidate traits had low to moderate heritability (0.10 ± 0.09 to 0.21 ± 0.10), with residual methane production corrected for ECM being the highest. All definitions of residual methane were highly correlated phenotypically (>0.87) and genetically (>0.79) with one another and moderately to highly with other methane candidate traits (>0.59), with high standard errors. The results suggest that direct selection for a residual methane production trait would result in indirect, favorable improvement in all other methane traits. The high standard errors highlight the importance of expanding data sets by measuring more animals for their methane emissions and DMI, or through exploration of proxy traits and combining data via international collaboration.


Assuntos
Bovinos/metabolismo , Metano/metabolismo , Animais , Austrália , Peso Corporal/genética , Bovinos/genética , Indústria de Laticínios , Dieta/veterinária , Feminino , Genoma , Gases de Efeito Estufa , Lactação , Leite , Fenótipo , Gravidez , Seleção Artificial
6.
Animal ; 14(1): 171-179, 2020 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-31327334

RESUMO

Feed represents a substantial proportion of production costs in the dairy industry and is a useful target for improving overall system efficiency and sustainability. The objective of this study was to develop methodology to estimate the economic value for a feed efficiency trait and the associated methane production relevant to Canada. The approach quantifies the level of economic savings achieved by selecting animals that convert consumed feed into product while minimizing the feed energy used for inefficient metabolism, maintenance and digestion. We define a selection criterion trait called Feed Performance (FP) as a 1 kg increase in more efficiently used feed in a first parity lactating cow. The impact of a change in this trait on the total lifetime value of more efficiently used feed via correlated selection responses in other life stages is then quantified. The resulting improved conversion of feed was also applied to determine the resulting reduction in output of emissions (and their relative value based on a national emissions value) under an assumption of constant methane yield, where methane yield is defined as kg methane/kg dry matter intake (DMI). Overall, increasing the FP estimated breeding value by one unit (i.e. 1 kg of more efficiently converted DMI during the cow's first lactation) translates to a total lifetime saving of 3.23 kg in DMI and 0.055 kg in methane with the economic values of CAD $0.82 and CAD $0.07, respectively. Therefore, the estimated total economic value for FP is CAD $0.89/unit. The proposed model is robust and could also be applied to determine the economic value for feed efficiency traits within a selection index in other production systems and countries.


Assuntos
Poluição do Ar/economia , Indústria de Laticínios/economia , Ingestão de Alimentos , Metano/economia , Animais , Canadá , Bovinos , Dieta/veterinária , Metano/metabolismo
7.
J Dairy Sci ; 102(12): 11142-11152, 2019 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-31587909

RESUMO

In this study, we estimated genetic parameters and genomic prediction accuracies of serum biomarkers of health in early-lactation dairy cows. A single serum sample was taken from 1,393 cows, located on 14 farms in southeastern Australia, within 30 d after calving. Sera were analyzed for biomarkers of energy balance (ß-hydroxybutyrate and fatty acids), macromineral status (Ca and Mg), protein nutritional status (urea and albumin), and immune status (globulins, albumin-to-globulin ratio, and haptoglobin). After editing, 47,162 SNP marker genotypes were used to estimate genomic heritabilities and breeding values (GEBV) for these traits in ASReml. Heritabilities were low for ß-hydroxybutyrate, fatty acids, Ca, Mg, and urea (0.09 ± 0.04, 0.18 ± 0.05, 0.07 ± 0.04, 0.19 ± 0.06, and 0.18 ± 0.05, respectively), and moderate for albumin, globulins, and albumin-to-globulin ratio (0.27 ± 0.06, 0.46 ± 0.06, and 0.41 ± 0.06, respectively). The heritability of haptoglobin concentration was close to 0. The magnitude of genetic correlations between traits (estimated using bivariate models) varied considerably (0.01 to 0.96), and standard errors of these correlations were high (0.02 to 0.44). Interestingly, the direction of most genetic correlations was favorable, suggesting that selecting for more optimal concentrations of one biomarker may result in more optimal concentrations of other biomarkers. Correlations between biomarker GEBV and existing breeding values for survival, somatic cell count, and daughter fertility were small to moderate (0.07 to 0.45) and favorable, whereas correlations with breeding values for milk production traits were small (≤0.15). Accuracies of GEBV were evaluated by using 5-fold cross validation, and by calculating accuracies from prediction error variances associated with the GEBV. Accuracies of GEBV predicted using 5-fold cross validation were low (0.05 to 0.27), whereas the means of individual accuracies were greater, ranging from 0.31 to 0.51. Although increasing the size of the reference population should theoretically improve accuracies, our results suggest that genomic prediction of health biomarkers may allow identification of cows that are less susceptible to diseases in early lactation.


Assuntos
Biomarcadores/sangue , Bovinos/sangue , Genômica , Indicadores Básicos de Saúde , Lactação/genética , Ácido 3-Hidroxibutírico/sangue , Animais , Cruzamento , Bovinos/genética , Ácidos Graxos/sangue , Feminino , Fertilidade , Genótipo , Fenótipo
8.
Lung Cancer ; 48(1): 47-57, 2005 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-15777970

RESUMO

UNLABELLED: Both cyclooxygenase (COX)-2 and epidermal growth factor receptor (EGFR) are thought to play important roles in the pathogenesis of non-small cell lung cancer (NSCLC). A number of in vitro studies have postulated a link between EGFR activation and subsequent COX-2 upregulation. The relationship between these factors has not been established in patients with NSCLC. COX-2 and EGFR expression were studied in 172 NSCLC specimens using standard immunohistochemical techniques. Western blotting was used to determine COX-2 and EGFR levels in five NSCLC cell lines. The effect of treatment with EGF on COX-2 expression in A549 cells was assessed. RESULTS: Both EGFR and COX-2 are overexpressed in NSCLC. The predominant pattern of COX-2 and EGFR staining was cytoplasmic. Membranous EGFR staining was seen in 23.3% of cases. There was no relationship between COX-2 and EGFR expression and survival or any clinicopathological features. No correlation was seen between EGFR expression and COX-2 expression in the immunohistochemical series or in the cell lines. Treatment with EGF did not upregulate COX-2 levels in A549 cells, either in serum free or serum-supplemented conditions. CONCLUSIONS: Although COX-2 and EGFR are over-expressed in NSCLC neither was of prognostic significance in this series of cases. There is no correlation between these two factors in either tumour samples or cell lines. Although these factors show no correlation in NSCLC, they remain potential, though independent targets for treatment.


Assuntos
Biomarcadores Tumorais/análise , Carcinoma Pulmonar de Células não Pequenas/genética , Receptores ErbB/biossíntese , Perfilação da Expressão Gênica , Neoplasias Pulmonares/genética , Prostaglandina-Endoperóxido Sintases/biossíntese , Idoso , Western Blotting , Carcinoma Pulmonar de Células não Pequenas/patologia , Carcinoma Pulmonar de Células não Pequenas/cirurgia , Ciclo-Oxigenase 2 , Citoplasma , Receptores ErbB/análise , Receptores ErbB/genética , Feminino , Humanos , Imuno-Histoquímica , Neoplasias Pulmonares/patologia , Neoplasias Pulmonares/cirurgia , Masculino , Proteínas de Membrana , Prognóstico , Prostaglandina-Endoperóxido Sintases/análise , Prostaglandina-Endoperóxido Sintases/genética , Análise de Sobrevida , Células Tumorais Cultivadas , Regulação para Cima
10.
Neurosci Lett ; 351(1): 13-6, 2003 Nov 06.
Artigo em Inglês | MEDLINE | ID: mdl-14550902

RESUMO

Extracellular recordings were made from supraoptic oxytocin (OT) neurones in rat brain slices to investigate the effect of reproductive state on their excitation by OT and cholecystokinin (CCK). Stable background activity was induced by local glutamate application, and OT neurones were identified by their continuous firing and opioid inhibition. The excitatory effect of OT (indicated by percentage neurones excited, peak increment in firing, and response magnitude) was maximal in lactating rats, intermediate in virgin, and lowest in pregnant animals. Excitation by CCK was high in both lactating and virgin rats but, as with OT tests, was minimal in the pregnant group. These adaptations in the responses to OT and CCK may help to ensure that the firing of OT neurones is appropriately regulated to meet changing demands for OT release.


Assuntos
Colecistocinina/fisiologia , Lactação/fisiologia , Neurônios/fisiologia , Ocitocina/fisiologia , Prenhez/fisiologia , Potenciais de Ação , Animais , Encéfalo/citologia , Encéfalo/efeitos dos fármacos , Encéfalo/fisiologia , Colecistocinina/farmacologia , Feminino , Técnicas In Vitro , Lactação/efeitos dos fármacos , Neurônios/efeitos dos fármacos , Neurônios/metabolismo , Ocitocina/farmacologia , Gravidez , Prenhez/efeitos dos fármacos , Ratos , Ratos Wistar , Comportamento Sexual Animal/efeitos dos fármacos , Comportamento Sexual Animal/fisiologia
12.
Lung Cancer ; 39(1): 1-13, 2003 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-12499088

RESUMO

The epidermal growth factor receptor (EGFR) is part of a family of plasma membrane receptor tyrosine kinases that control many important cellular functions, from growth and proliferation to cell death. Cyclooxygenase (COX)-2 is an enzyme which catalyses the conversion of arachidonic acid to prostagladins and thromboxane. It is induced by various inflammatory stimuli, including the pro-inflammatory cytokines, Interleukin (IL)-1beta, Tumour Necrosis Factor (TNF)-alpha and IL-2. Both EGFR and COX-2 are over-expressed in non-small cell lung cancer (NSCLC) and have been implicated in the early stages of tumourigenesis. This paper considers their roles in the development and progression of lung cancer, their potential interactions, and reviews the recent progress in cancer therapies that are directed toward these targets. An increasing body of evidence suggests that selective inhibitors of both EGFR and COX-2 are potential therapeutic agents for the treatment of NSCLC, in the adjuvant, metastatic and chemopreventative settings.


Assuntos
Carcinoma Pulmonar de Células não Pequenas/tratamento farmacológico , Carcinoma Pulmonar de Células não Pequenas/metabolismo , Receptores ErbB/metabolismo , Isoenzimas/metabolismo , Neoplasias Pulmonares/tratamento farmacológico , Neoplasias Pulmonares/metabolismo , Prostaglandina-Endoperóxido Sintases/metabolismo , Carcinoma Pulmonar de Células não Pequenas/patologia , Ensaios Clínicos como Assunto , Ciclo-Oxigenase 2 , Humanos , Neoplasias Pulmonares/patologia , Proteínas de Membrana
13.
Br J Radiol ; 75(897): 731-5, 2002 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-12200241

RESUMO

Percutaneous transthoracic lung biopsies are commonly performed for the investigation of lung masses. We describe current practice and complication rates in the UK. A postal questionnaire was sent to all centres in the British Thoracic Society directory. 157 replies (61% response rate) were received, providing data on 5444 biopsies. Mean number of biopsies performed per annum was 30.5 per centre; 8% of centres did not perform biopsies, 36% performed <25 biopsies per annum, 34% <50, 16% <100 and 6% >100. Consultant radiologists perform 91% of biopsies. Written consent was obtained at all centres. The operator obtained consent at 50% of centres. Written information for patients was provided at 35 (24%) centres. Biopsies are performed on a day case basis at 103 (71%) centres. Prior to biopsy the following were obtained routinely: CT scan (73% of centres), platelet count (73%), full clotting screen (70%), lung function (55%). Complications included pneumothorax (20.5% of biopsies), pneumothorax requiring chest drain (3.1%), haemoptysis (5.3%) and death (0.15%). The timing of post-procedure chest radiography was variable. Those centres that performed predominantly cutting needle biopsies had similar pneumothorax rates to centres performing mainly fine needle biopsies (18.9% vs 18.3%). There is great variation in practice throughout the UK. Most procedures are performed on a daycase basis. Small pneumothoraces are common but infrequently require treatment. National guidelines are needed to ensure consistency of standards.


Assuntos
Pesquisas sobre Atenção à Saúde , Pneumopatias/patologia , Pulmão/patologia , Biópsia/efeitos adversos , Biópsia/métodos , Biópsia/estatística & dados numéricos , Biópsia por Agulha/estatística & dados numéricos , Humanos , Reino Unido
15.
J Neuroendocrinol ; 12(9): 843-52, 2000 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-10971809

RESUMO

The mesencephalic ventral tegmentum has been implicated in the milk-ejection reflex and modulation of inputs from this region could provide a mechanism whereby central oxytocin facilitates synchronous bursting of oxytocin neurones during suckling. Experiments were therefore undertaken to investigate the effect of intracerebroventricular (i.c.v.) oxytocin on the response of oxytocin neurones to ventral tegmental stimulation. Oxytocin neurones were recorded in the supraoptic nucleus of urethane-anaesthetized lactating rats during suckling, and their response to single shock stimulation of the ventral tegmentum was monitored using peri-stimulus time-interval histograms. Before i.c.v. oxytocin, oxytocin neurones were either unresponsive to ventral tegmental stimulation, or displayed a small inhibition. However, after administration of oxytocin (2.2 ng i.c.v.), seven out of eight neurones tested displayed a pronounced excitatory response (onset latency 78.4 +/- 4.8 ms, duration 73.4 +/- 8.3 ms). This permissive effect on the excitatory response was only observed in the presence of suckling, and followed the same time course as facilitation of the milk-ejection reflex, being maximal immediately before each facilitated bursting response in the oxytocin neurones. The response to ventral tegmental stimulation remained unaltered after intraperitoneal administration of hypertonic saline to cause a generalized increase in the excitability of the oxytocin neurones. Moreover, i.c.v. oxytocin had no effect on the response of oxytocin neurones to stimulation of a descending input from the medial septum. In conclusion, administration of i.c.v. oxytocin has a selective permissive effect on the excitation of oxytocin neurones from the ventral tegmentum, and this supports previous in vitro studies suggesting that centrally released oxytocin may act as a modulator of afferent transmission to the magnocellular nuclei. This effect on the afferent excitation of oxytocin neurones may provide a mechanism whereby i.c.v. oxytocin facilitates suckling-evoked bursting activity.


Assuntos
Lactação/fisiologia , Neurônios/fisiologia , Ocitocina/administração & dosagem , Ocitocina/fisiologia , Potenciais de Ação , Animais , Estimulação Elétrica , Eletrodos , Feminino , Injeções Intraventriculares , Cinética , Ejeção Láctea/fisiologia , Ocitocina/farmacologia , Ratos , Ratos Wistar , Reprodutibilidade dos Testes , Comportamento de Sucção
16.
Biochemistry ; 39(20): 6003-11, 2000 May 23.
Artigo em Inglês | MEDLINE | ID: mdl-10821672

RESUMO

This paper describes the design and characterization of novel inhibitors of IleRS, whose binding affinity approaches the tightest reported for noncovalent inhibition. Compounds were designed from a binding model for the natural product pseudomonic acid-A (PS-A) together with a detailed understanding of the reaction cycle of IleRS and characterization of the mode of binding of the reaction intermediate IleAMP. The interactions of the compounds with IleRS were characterized by inhibition of aminoacylation of tRNA or PP(i)/ATP exchange at supersaturating substrate concentration and by transient kinetics and calorimetry methods. A detailed understanding of the interaction of a comprehensive series of compounds with IleRS allowed the identification of key features and hence the design of exquisitely potent inhibitors. Predictions based on these results have been recently supported by a docking model based on the crystal structure of IleRS with PS-A [Silvian, L. F., Wang J. M., and Steitz T. A. (1999) Science 285 1074-1077].


Assuntos
Antibacterianos/química , Inibidores Enzimáticos/síntese química , Isoleucina-tRNA Ligase/antagonistas & inibidores , Isoleucina-tRNA Ligase/química , Modelos Moleculares , Mupirocina/química , Antibacterianos/metabolismo , Sítios de Ligação , Varredura Diferencial de Calorimetria , Dicroísmo Circular , Inibidores Enzimáticos/metabolismo , Estabilidade Enzimática , Isoleucina/química , Isoleucina/metabolismo , Isoleucina-tRNA Ligase/metabolismo , Cinética , Modelos Químicos , Mupirocina/metabolismo , Espectrometria de Fluorescência , Staphylococcus aureus/enzimologia , Relação Estrutura-Atividade , Termodinâmica
17.
Biol Psychiatry ; 46(1): 73-7, 1999 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-10394475

RESUMO

BACKGROUND: Treatment-resistance in schizophrenia remains a public health problem. Clozapine has been shown to be effective in about one third of this population, but carries with it medical risks and weekly blood draws. As olanzapine is a drug with a very similar biochemical profile to clozapine, it is important to evaluate whether non-response to olanzapine predicts clozapine non-response. METHODS: Forty-four treatment-resistant patients received eight weeks of olanzapine, either in a double-blind trial or subsequent open treatment at a mean daily dose of 25 mg/day. Two of 44 patients (5%) responded to olanzapine treatment. Patients who did not respond could then receive clozapine. Twenty-seven subsequently received an 8-week open trial of clozapine. RESULTS: Patients who did and did not receive clozapine did not differ demographically or in psychopathology. Eleven of 27 (41%) met a priori response criteria during clozapine treatment (mean dose 693 mg/day) after failing to respond to olanzapine. CONCLUSIONS: This study demonstrates that failure to respond to olanzapine treatment does not predict failure to clozapine. Treatment-resistant patients who fail on olanzapine may benefit from a subsequent trial of clozapine.


Assuntos
Antipsicóticos/uso terapêutico , Clozapina/uso terapêutico , Pirenzepina/análogos & derivados , Esquizofrenia/tratamento farmacológico , Adulto , Benzodiazepinas , Método Duplo-Cego , Resistência a Medicamentos , Feminino , Humanos , Masculino , Olanzapina , Pirenzepina/uso terapêutico , Resultado do Tratamento
18.
Bioorg Med Chem ; 7(11): 2473-85, 1999 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-10632057

RESUMO

Molecular modelling and synthetic studies have been carried out on tyrosinyl adenylate and analogues to probe the interactions seen in the active site of the X-ray crystal structure of tyrosyl tRNA synthetase from Bacillus stearothermophilus, and to search for new inhibitors of this enzyme. Micromolar and sub-micromolar inhibitors of tyrosyl tRNA synthetases from both B. stearothermophilus and Staphylococcus aureus have been synthesised. The importance of the adenine ring to the binding of tyrosinyl adenylate to the enzyme, and the importance of water-mediated hydrogen bonding interactions, have been highlighted. The inhibition data has been further supported by homology modelling with the S. aureus enzyme, and by ligand docking studies.


Assuntos
Monofosfato de Adenosina/análogos & derivados , Geobacillus stearothermophilus/enzimologia , Tirosina-tRNA Ligase/metabolismo , Tirosina/análogos & derivados , Adenina/metabolismo , Monofosfato de Adenosina/química , Monofosfato de Adenosina/metabolismo , Sequência de Aminoácidos , Sítios de Ligação , Inibidores Enzimáticos/síntese química , Inibidores Enzimáticos/química , Inibidores Enzimáticos/farmacologia , Geobacillus stearothermophilus/genética , Modelos Moleculares , Dados de Sequência Molecular , Fosfatos/metabolismo , Ligação Proteica , Ribose/metabolismo , Homologia de Sequência de Aminoácidos , Staphylococcus aureus/enzimologia , Staphylococcus aureus/genética , Tirosina/química , Tirosina/metabolismo , Tirosina-tRNA Ligase/antagonistas & inibidores , Tirosina-tRNA Ligase/genética
19.
J Neuroendocrinol ; 10(11): 829-37, 1998 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-9831259

RESUMO

The neurosteroid pregnenolone sulphate (PS) interacts allosterically with ionotropic glutamate receptors and thereby could be an important modulator of activity within the hypothalamic magnocellular nuclei. The present in-vitro study therefore examined the effect of perifusion of PS (100 microM) on activity of supraoptic oxytocin (OT) and vasopressin (VP) neurones, in which firing was stimulated by local application of glutamate, NMDA or AMPA. In the presence of locally applied glutamate, PS significantly potentiated firing in putative VP neurones, but had little effect on putative OT neurones. In both cell types, PS increased firing in the presence of NMDA and depressed firing in the presence of AMPA. The action of PS on glutamate- and NMDA-stimulated firing was unaffected by addition of the GABA(A) receptor antagonist, picrotoxin (50 microM). The suppressive action of PS on AMPA-stimulated firing was, however, reversed by picrotoxin and therefore probably requires intact GABAergic transmission for its expression. When putative VP neurones were stimulated by local application of K+, in the presence of picrotoxin, PS evoked a small increase in the ongoing activity, although this did not reach significance. When the glutamate receptor antagonists, NBQX (20 microM) and AP5 (40 microM), were included in the medium, no change in K+ -stimulated firing was observed. Hence PS has no effect on activity of putative VP neurones in the absence of exogenous and endogenous glutamate excitation. In conclusion, PS selectively potentiates glutamate-stimulated activity in putative VP neurones, probably via NMDA receptors, thus providing a mechanism whereby this neurosteroid might exert rapid non-genomic effects on VP secretion. The lack of effect of PS in putative OT neurones probably relates to the relatively small involvement of NMDA receptors in mediating glutamate excitation in this cell type.


Assuntos
Neurônios/efeitos dos fármacos , Neurônios/metabolismo , Ocitocina/metabolismo , Pregnenolona/farmacologia , Núcleo Supraóptico/metabolismo , Vasopressinas/metabolismo , Animais , Eletrofisiologia , Agonistas de Aminoácidos Excitatórios/farmacologia , Feminino , Ácido Glutâmico/farmacologia , N-Metilaspartato/farmacologia , Neurônios/fisiologia , Ratos , Ratos Wistar , Núcleo Supraóptico/citologia , Núcleo Supraóptico/efeitos dos fármacos , Ácido alfa-Amino-3-hidroxi-5-metil-4-isoxazol Propiônico/farmacologia
20.
Benefits Q ; 14(1): 9-16, 1998.
Artigo em Inglês | MEDLINE | ID: mdl-10177709

RESUMO

The following article attempts to bring to light the many questions and thoughts regarding ethical behavior as it relates to the employee benefits profession. Rather than dictating to the reader all the answers regarding ethics, the article demonstrates the different ways various situations can be interpreted. It leaves open the choices available to employee benefits professionals, while compelling us to confront the difficult decisions we must face when dealing with employees, employers and insurance companies.


Assuntos
Ética Institucional , Planos de Assistência de Saúde para Empregados/normas , Gestão de Recursos Humanos/normas , Salários e Benefícios , Planos de Assistência de Saúde para Empregados/legislação & jurisprudência , Indústrias/normas , Cobertura do Seguro , Programas de Assistência Gerenciada , Estados Unidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...